{"id":"https://openalex.org/W2086199047","doi":"https://doi.org/10.4155/fmc.11.133","title":"Novel Cosuspension Metered-Dose Inhalers for the Combination Therapy of Chronic Obstructive Pulmonary Disease and Asthma","display_name":"Novel Cosuspension Metered-Dose Inhalers for the Combination Therapy of Chronic Obstructive Pulmonary Disease and Asthma","publication_year":2011,"publication_date":"2011-09-23","ids":{"openalex":"https://openalex.org/W2086199047","doi":"https://doi.org/10.4155/fmc.11.133","mag":"2086199047","pmid":"https://pubmed.ncbi.nlm.nih.gov/21942257"},"language":"en","primary_location":{"id":"doi:10.4155/fmc.11.133","doi":"https://doi.org/10.4155/fmc.11.133","is_oa":false,"landing_page_url":"https://doi.org/10.4155/fmc.11.133","pdf_url":null,"source":{"id":"https://openalex.org/S122867665","display_name":"Future Medicinal Chemistry","issn_l":"1756-8919","issn":["1756-8919","1756-8927"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Medicinal Chemistry","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091664560","display_name":"David Lechuga\u2010Ballesteros","orcid":"https://orcid.org/0000-0002-3002-1158","observed_orcids":["https://orcid.org/0000-0002-3002-1158"]},"institutions":[{"id":"https://openalex.org/I4405280598","display_name":"Pearl Therapeutics (United States)","ror":"https://ror.org/035cg8y37","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756","https://openalex.org/I4405280598"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Lechuga-Ballesteros","raw_affiliation_strings":["Pearl Therapeutics, Inc., 200 Saginaw Drive, Redwood City, CA94063, USA","Pearl Therapeutics, Inc., 200 Saginaw Drive, Redwood City, CA 94063, USA. dlechuga@ pearltherapeutics.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pearl Therapeutics, Inc., 200 Saginaw Drive, Redwood City, CA94063, USA","institution_ids":["https://openalex.org/I4405280598"]},{"raw_affiliation_string":"Pearl Therapeutics, Inc., 200 Saginaw Drive, Redwood City, CA 94063, USA. dlechuga@ pearltherapeutics.com","institution_ids":["https://openalex.org/I4405280598"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037897478","display_name":"Brian Noga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405280598","display_name":"Pearl Therapeutics (United States)","ror":"https://ror.org/035cg8y37","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756","https://openalex.org/I4405280598"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian Noga","raw_affiliation_strings":["Pearl Therapeutics, Inc., 200 Saginaw Drive, Redwood City, CA94063, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pearl Therapeutics, Inc., 200 Saginaw Drive, Redwood City, CA94063, USA","institution_ids":["https://openalex.org/I4405280598"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045378562","display_name":"Reinhard Vehring","orcid":"https://orcid.org/0000-0002-4446-9826","observed_orcids":["https://orcid.org/0000-0002-4446-9826"]},"institutions":[{"id":"https://openalex.org/I154425047","display_name":"University of Alberta","ror":"https://ror.org/0160cpw27","country_code":"CA","type":"education","lineage":["https://openalex.org/I154425047"]},{"id":"https://openalex.org/I4405280598","display_name":"Pearl Therapeutics (United States)","ror":"https://ror.org/035cg8y37","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756","https://openalex.org/I4405280598"]}],"countries":["CA","US"],"is_corresponding":false,"raw_author_name":"Reinhard Vehring","raw_affiliation_strings":["Pearl Therapeutics, Inc., 200 Saginaw Drive, Redwood City, CA94063, USA","University of Alberta, Edmonton, AB, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pearl Therapeutics, Inc., 200 Saginaw Drive, Redwood City, CA94063, USA","institution_ids":["https://openalex.org/I4405280598"]},{"raw_affiliation_string":"University of Alberta, Edmonton, AB, Canada","institution_ids":["https://openalex.org/I154425047"]}]},{"author_position":"middle","author":{"id":null,"display_name":"R Harris Cummings","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405280598","display_name":"Pearl Therapeutics (United States)","ror":"https://ror.org/035cg8y37","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756","https://openalex.org/I4405280598"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R Harris Cummings","raw_affiliation_strings":["Pearl Therapeutics, Inc., 200 Saginaw Drive, Redwood City, CA94063, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pearl Therapeutics, Inc., 200 Saginaw Drive, Redwood City, CA94063, USA","institution_ids":["https://openalex.org/I4405280598"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5004032785","display_name":"Sarvajna Dwivedi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405280598","display_name":"Pearl Therapeutics (United States)","ror":"https://ror.org/035cg8y37","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756","https://openalex.org/I4405280598"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarvajna K Dwivedi","raw_affiliation_strings":["Pearl Therapeutics, Inc., 200 Saginaw Drive, Redwood City, CA94063, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pearl Therapeutics, Inc., 200 Saginaw Drive, Redwood City, CA94063, USA","institution_ids":["https://openalex.org/I4405280598"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5328,"has_fulltext":false,"cited_by_count":57,"citation_normalized_percentile":{"value":0.45045632,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"3","issue":"13","first_page":"1703","last_page":"1718"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10920","display_name":"Advanced Drug Delivery Systems","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10143","display_name":"Chronic Obstructive Pulmonary Disease (COPD) Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metered-dose-inhaler","display_name":"MDI","score":0.9369999766349792},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7879999876022339},{"id":"https://openalex.org/keywords/chronic-obstructive-pulmonary-disease","display_name":"chronic obstructive pulmonary disease","score":0.9739999771118164},{"id":"https://openalex.org/keywords/asthma","display_name":"asthma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/aerosol-performance","display_name":"aerosol performance","score":0.8519999980926514},{"id":"https://openalex.org/keywords/pulmonary-drug-delivery","display_name":"pulmonary drug delivery","score":0.6729999780654907},{"id":"https://openalex.org/keywords/triple-therapy","display_name":"triple therapy","score":0.46799999475479126}],"concepts":[{"id":"https://openalex.org/C2780667556","wikidata":"https://www.wikidata.org/wiki/Q16897784","display_name":"Metered-dose inhaler","level":4,"score":0.8554527759552002},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8165279626846313},{"id":"https://openalex.org/C2776042228","wikidata":"https://www.wikidata.org/wiki/Q35869","display_name":"Asthma","level":2,"score":0.7667329907417297},{"id":"https://openalex.org/C2780261241","wikidata":"https://www.wikidata.org/wiki/Q1394363","display_name":"Inhaler","level":3,"score":0.6813400983810425},{"id":"https://openalex.org/C2992779976","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Pulmonary disease","level":2,"score":0.6073509454727173},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5741096138954163},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.442852258682251},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.4299898147583008},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4219011664390564},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.148868590593338}],"mesh":[{"descriptor_ui":"D001249","descriptor_name":"Asthma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D029424","descriptor_name":"Pulmonary Disease, Chronic Obstructive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D036501","descriptor_name":"Metered Dose Inhalers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.4155/fmc.11.133","doi":"https://doi.org/10.4155/fmc.11.133","is_oa":false,"landing_page_url":"https://doi.org/10.4155/fmc.11.133","pdf_url":null,"source":{"id":"https://openalex.org/S122867665","display_name":"Future Medicinal Chemistry","issn_l":"1756-8919","issn":["1756-8919","1756-8927"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:21942257","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21942257","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Future medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320333801","display_name":"Pearl Therapeutics","ror":"https://ror.org/035cg8y37"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":56,"referenced_works":["https://openalex.org/W8081792","https://openalex.org/W26894815","https://openalex.org/W613078476","https://openalex.org/W1484153881","https://openalex.org/W1504654291","https://openalex.org/W1566113502","https://openalex.org/W1607515676","https://openalex.org/W1734202001","https://openalex.org/W1862886500","https://openalex.org/W1967589531","https://openalex.org/W1968394560","https://openalex.org/W1970437544","https://openalex.org/W1973794743","https://openalex.org/W1974899942","https://openalex.org/W1975132504","https://openalex.org/W1982335735","https://openalex.org/W1986186916","https://openalex.org/W2009584558","https://openalex.org/W2019762520","https://openalex.org/W2022069744","https://openalex.org/W2022791140","https://openalex.org/W2025006682","https://openalex.org/W2030537658","https://openalex.org/W2038687277","https://openalex.org/W2039692723","https://openalex.org/W2045467856","https://openalex.org/W2050417299","https://openalex.org/W2050833508","https://openalex.org/W2055862513","https://openalex.org/W2056805649","https://openalex.org/W2057107937","https://openalex.org/W2058889783","https://openalex.org/W2065341819","https://openalex.org/W2071004669","https://openalex.org/W2073470094","https://openalex.org/W2074053180","https://openalex.org/W2074850707","https://openalex.org/W2083973238","https://openalex.org/W2102356444","https://openalex.org/W2102583457","https://openalex.org/W2111530512","https://openalex.org/W2112135623","https://openalex.org/W2139491055","https://openalex.org/W2141222317","https://openalex.org/W2145606419","https://openalex.org/W2151383616","https://openalex.org/W2155854731","https://openalex.org/W2166209362","https://openalex.org/W2169869727","https://openalex.org/W2190551119","https://openalex.org/W2319434591","https://openalex.org/W2328043439","https://openalex.org/W2329162318","https://openalex.org/W2478493678","https://openalex.org/W2783974044","https://openalex.org/W4245587948"],"related_works":["https://openalex.org/W2757794515","https://openalex.org/W2035487619","https://openalex.org/W3123416722","https://openalex.org/W7135839280","https://openalex.org/W2102193666","https://openalex.org/W2167479202","https://openalex.org/W1711405190","https://openalex.org/W6921995833","https://openalex.org/W2327566661","https://openalex.org/W2014539446"],"abstract_inverted_index":{"Pressurized":[0],"metered":[1,74],"dose":[2,75],"inhaler":[3,76],"is":[4,90],"the":[5,15,48,58,116],"most":[6],"common":[7],"inhaled":[8],"dosage":[9],"form,":[10],"ideally":[11],"suited":[12],"for":[13,24,34],"delivering":[14],"highly":[16],"potent":[17],"compounds":[18],"that":[19],"medicinal":[20],"chemists":[21],"typically":[22],"discover":[23],"respiratory":[25,86],"therapeutic":[26,87],"targets.":[27],"The":[28],"clinical":[29,105],"benefit":[30],"of":[31,47,67,84,118],"combination":[32,61,111],"therapy":[33],"asthma":[35],"and":[36,45,104],"chronic":[37],"obstructive":[38],"pulmonary":[39],"disease":[40],"has":[41],"been":[42],"well":[43],"established,":[44],"many":[46],"new":[49],"discovery":[50],"candidates":[51],"are":[52],"likely":[53],"to":[54,79],"be":[55],"studied":[56],"in":[57,110,119],"clinic":[59],"as":[60],"drugs":[62],"even":[63],"at":[64],"early":[65],"stages":[66],"development.":[68],"We":[69],"present":[70],"a":[71,85,93],"novel":[72],"pressurized":[73],"formulation":[77],"approach":[78],"enable":[80,101],"consistent":[81],"aerosol":[82],"performance":[83,121],"whether":[88,107],"it":[89],"emitted":[91],"from":[92],"single-,":[94],"double-":[95],"or":[96,109],"triple-therapy":[97],"product.":[98],"This":[99],"should":[100],"rapid":[102],"nonclinical":[103],"assessment":[106],"alone":[108],"with":[112],"other":[113],"drugs,":[114],"without":[115],"challenge":[117],"vitro":[120],"dissimilarity":[122],"across":[123],"product":[124],"types.":[125]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}